Revolution Medicines, Inc. is 4.8x more valuable than Immunovant, Inc. by market capitalization ($30.65 B vs $6.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMVT | RVMD |
|---|---|---|
| Market cap | $6.40 B | $30.65 B |
| US-listed rank | #1219 | #454 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$505.61M | -$1.13B |
| SEC filings | 611 | 782 |
Revolution Medicines, Inc. is 4.8x more valuable than Immunovant, Inc. by market capitalization ($30.65 B vs $6.40 B).
Full pages: Immunovant, Inc. and Revolution Medicines, Inc., or browse the full rankings.